- Q1 0 —
- Q2 0 —
- Q3 0 —
- Q4 0 —
Academician
MANSUR AZERMİR
Doktor Öğretim Üyesi
Citation impact
OpenAlex YÖKSİS articles matched in OpenAlex: 3- i10-index
- 0
- Total citations
- 0 Top 100% in Türkiye
- Per article
- 0.0
- FWCI
- 0.00 1.00 = world average
- World top 1%
- 0
- World top 10%
- 0
h-index and citations are computed from the citation counts of this academic’s YÖKSİS articles matched in OpenAlex (not Google Scholar, WoS or Scopus). Unmatched articles are not included.
Collaboration network
From the author lists of YÖKSİS publication records. Duplicate records of a work count once; institutions are co-authors’ current YÖKSİS affiliations.
- Co-authors
- 7
- With an akaturk profile
- 4
- Turkish institutions
- 3
- Co-authored works
- %100
Academic co-authors 4
- MUSTAFA TEMİZEL Doçent · İstanbul Yeni Yüzyıl Üniversitesi 3
- YÜCEL ARMAN Profesör · Sağlık Bilimleri Üniversitesi 2
- BURAK ÖNAL Doçent · Biruni Üniversitesi same university 1
- ZELİHA ARSLAN ULUKAN Profesör · İstanbul Aydın Üniversitesi 1
National collaboration 3 institutions
Within own university1 joint works · Biruni Üniversitesi
- İstanbul Yeni Yüzyıl Üniversitesi 3 works · 1 academics
- Sağlık Bilimleri Üniversitesi 2 works · 1 academics
- İstanbul Aydın Üniversitesi 1 works · 1 academics
Other co-authors (incl. international) 3
MURTAZA ÇİT 2UĞUR DİLEK CALAP 2MÜJGAN ORMAN
Authors without an akaturk profile (international researchers, retired or former academics, students, clinicians) are grouped by name spelling; short forms such as “Gulluce M.” join the single full name they match.
Index quartiles
?- Q1 0 —
- Q2 0 —
- Q3 0 —
- Q4 0 —
Articles
Articles with YÖKSİS and OpenAlex source split; narrow by quartile or TR Index.
Journals with publications
3 journals
Narrow down
Article list
- 2021 Frequency of Refractory Hypertension in Turkish Patients and Evaluation of the Factors Affecting Refractory Hypertension YÖKSİS OpenAlex 1.3%
- 2021 Well Controlled Blood Pressure in Turkish Patients: How Many Drugs Are Required to Attain and Maintain the Blood Pressure Goal? YÖKSİS OpenAlex 1.0%
- 2021 Tocilizumab Treatment Affects Intensive Care Unit Admission Rates of COVID-19 Patients in a Dose-dependent Manner YÖKSİS TR Index OpenAlex 11.2%